These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 31638189)

  • 21. Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease.
    Paul BD; Sbodio JI; Xu R; Vandiver MS; Cha JY; Snowman AM; Snyder SH
    Nature; 2014 May; 509(7498):96-100. PubMed ID: 24670645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bim contributes to the progression of Huntington's disease-associated phenotypes.
    Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S
    Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.
    Hakim-Eshed V; Boulos A; Cohen-Rosenzweig C; Yu-Taeger L; Ziv T; Kwon YT; Riess O; Phuc Nguyen HH; Ziv NE; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18661-18669. PubMed ID: 32675242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease.
    Ramírez-Jarquín UN; Sharma M; Zhou W; Shahani N; Subramaniam S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35086928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion.
    Sharma M; Subramaniam S
    J Cell Biol; 2019 Jun; 218(6):1972-1993. PubMed ID: 31076452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
    Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
    Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model.
    Pan Y; Tang B; Li XJ; Li S; Liu Q
    Front Aging Neurosci; 2023; 15():1237018. PubMed ID: 37637962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curbing Rhes Actions: Mechanism-based Molecular Target for Huntington's Disease and Tauopathies.
    Subramaniam S; Boregowda S
    CNS Neurol Disord Drug Targets; 2024; 23(1):21-29. PubMed ID: 36959146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.
    Creus-Muncunill J; Ehrlich ME
    Neurotherapeutics; 2019 Oct; 16(4):957-978. PubMed ID: 31529216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.
    Chen L; Qin Y; Guo T; Zhu W; Lin J; Xing T; Duan X; Zhang Y; Ruan E; Li X; Yin P; Li S; Li XJ; Yang S
    Cell Death Dis; 2024 May; 15(5):337. PubMed ID: 38744826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lycium barbarum polysaccharide attenuates the cytotoxicity of mutant huntingtin and increases the activity of AKT.
    Fang F; Peng T; Yang S; Wang W; Zhang Y; Li H
    Int J Dev Neurosci; 2016 Aug; 52():66-74. PubMed ID: 27196502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhes suppression enhances disease phenotypes in Huntington's disease mice.
    Lee JH; Sowada MJ; Boudreau RL; Aerts AM; Thedens DR; Nopoulos P; Davidson BL
    J Huntingtons Dis; 2014; 3(1):65-71. PubMed ID: 25062765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.
    Lee YH; Tsai YS; Chang CC; Ho CC; Shih HM; Chen HM; Lai HL; Lee CW; Lee YC; Liao YC; Yang UC; Cheng TH; Chern Y; Soong BW
    Mov Disord; 2022 Apr; 37(4):767-777. PubMed ID: 34951052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
    Lee CY; Cantle JP; Yang XW
    FEBS J; 2013 Sep; 280(18):4382-94. PubMed ID: 23829302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.